In this article from International Biopharmaceutical Industry, Dr. Chad Galderisi, Vice President and Global Medical Director for ICON Specialty Laboratories explores how unique applications of PCR and flow cytometry can be used to provide critical and complementary data that is needed to bring new life-saving treatment options to patients.

Published by International Biopharmaceutical Industry Journal Volume 6 Issue 3